Regarding the [177Lu]Lu-NeoB therapeutic potential here, it seems to be at least similar if not better than others 177Lu-radiolabeled GRPR antagonists, such as [177Lu]Lu-JMV4168, which was evaluated in PC-3 tumor bearing mice. The gene discussed is GRPR; the disease is neoplasm.